CIK 0001527753
- Non-accelerated filer
- Smaller reporting company
Personalis, Inc.
Sign in to watch- Ticker
- PSNL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275411038
- Phone
- +1 650-752-1300
- Business address
- 6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
- 4 Option exercise President and CEO acquired 10,000 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 4,360 shares at $2.60 ($11,336)
- 4 Open-market sale Chief Medical Officer sold 440 shares at $2.60 ($1,144)
- 4 Open-market sale Chief Medical Officer sold 1,295 shares at $2.71 ($3,509)
- 4 Open-market sale General Counsel sold 2,045 shares at $2.71 ($5,542)
- 4 Open-market sale Chief Financial Officer sold 1,294 shares at $2.71 ($3,507)
- 4 Open-market sale Chief Medical Officer sold 1,581 shares at $3.48 ($5,502)
- 4 Open-market sale Chief Financial Officer sold 3,474 shares at $3.48 ($12,090)
- 4 Open-market sale Chief Medical Officer sold 420 shares at $3.33 ($1,399)
- 4 Open-market sale Chief Financial Officer sold 4,168 shares at $3.33 ($13,879)
- 4 Grant or award General Counsel acquired 18,600 shares (grant or award)
- 4 Grant or award General Counsel acquired 18,600 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 230,000 shares (grant or award)
- 4 Grant or award Director acquired 30,940 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 632 shares at $3.91 ($2,471)
- 4 Open-market sale Chief Financial Officer sold 632 shares at $3.91 ($2,471)
- 4 Open-market sale Chief Medical Officer sold 1,565 shares at $3.29 ($5,149)
Page 7 of 15 · 289 filings